Found 5 matching trials
Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia
PHASE1This is a single center Phase I clinical trial of FT538 administered intrav...
Location
Masonic Cancer Center at University of Minnesota
FT538 in Subjects With Advanced Hematologic Malignancies
PHASE1This is a Phase I dose-finding study of FT538 as monotherapy in acute myelo...
Location
Colorado Blood Cancer Institute
FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors
PHASE1This is a Phase 1 dose-finding study of FT538 in combination with monoclona...
Location
Hackensack University Medical Center
FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia
PHASE1This Phase I open-label dose escalation study is conducted in two stages wi...
Location
Masonic Cancer Center, University of Minnesota
MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
PHASE1To determine the maximum tolerated dose (MTD) of FT538 monotherapy when adm...
Location
Masonic Cancer Center - University of Minnesota